Journal article
Modeling cost–effectiveness of pharmaceuticals in Alzheimer's disease
Abstract
Alzheimer's disease is a neurodegenerative disorder characterized by cognitive and behavioral deficits. Donepezil and memantine are two medications used to treat the symptoms of cognitive decline in Alzheimer's disease. A modeled cost-effectiveness analysis found that treatment with donepezil to be less costly and more effective than no treatment or treatment with memantine in Germany. However, the model drew on non-German population data and …
Authors
Oremus M; Tarride J-E
Journal
Expert Review of Pharmacoeconomics & Outcomes Research, Vol. 12, No. 3, pp. 275–277
Publisher
Taylor & Francis
Publication Date
6 2012
DOI
10.1586/erp.12.21
ISSN
1473-7167